Clinical Trials
20 trialsNCT03428373 2024-02-29
RithMM
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2/3 Unknown
NCT00565708 2024-02-02
ASCOLT
National Cancer Centre, Singapore
Phase 3 Unknown
NCT05402124 2022-06-02
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
Phase 2 Unknown
NCT01968798 2021-04-05
ACES
Hennepin Healthcare Research Institute
Phase 4 Unknown
NCT04256525 2020-06-30
Prophylactic Anticoagulation for Catheter-related Thrombosis
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Unknown
NCT03356769 2020-06-09
Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01936233 2019-08-05
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
Fudan University
Phase 3 Unknown
NCT03491410 2018-04-09
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Centro Hospitalar Lisboa Ocidental
Phase 2/3 Unknown
NCT03290820 2017-10-26
Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients
Sun Yat-sen University
Phase 2 Unknown
NCT02757365 2016-05-02
Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer
West China Hospital
Phase 4 Unknown
NCT02607072 2015-11-18
APREMEC
The Fourth Affiliated Hospital of Anhui Medical University
Phase 3 Unknown
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT02387086 2015-03-12
Gefitinib Combined With Thalidomide to Treat NSCLC
Shaanxi Provincial People's Hospital
Phase 2/3 Unknown
NCT02125409 2014-05-05
Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action
Aragon Institute of Health Sciences
Phase 3 Unknown
NCT00033319 2013-09-17
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
National Cancer Institute (NCI)
Phase NA Unknown
NCT01431053 2013-03-13
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01786200 2013-02-07
Physiological Effects of Altering Cancer-related Inflammation
NHS Greater Glasgow and Clyde
Phase NA Unknown
NCT01612247 2012-06-05
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
University of Vermont
Phase NA Unknown
NCT01549418 2012-03-09
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4 Unknown
NCT01496521 2011-12-21
CREAT
Beijing Friendship Hospital
Phase 3 Unknown